South African Mesothelioma Victims: US Trust Fund Eligibility

South Africa's Asbestos Legacy

South Africa was one of the world's largest asbestos producers from the late 1800s until the industry was banned in 2008. The country's mines produced all three commercial asbestos types — crocidolite (blue asbestos) from the Northern Cape and Western Cape, amosite (brown asbestos) primarily from the Northern Transvaal (now Limpopo Province), and chrysotile (white asbestos) from the Eastern Transvaal (now Mpumalanga). At its 1977 peak, the SA asbestos industry exported approximately 380,000 tonnes annually and employed about 20,000 miners.

The medical consequences continue to unfold. The Prieska birth-cohort epidemiological study documented mesothelioma mortality of 277 per million person-years — orders of magnitude above background rates seen in non-exposed populations. Mesothelioma's 30-to-50-year latency period means the case wave from peak-production-era exposure is still arriving and is expected to continue rising through the 2030s.

Three distinct exposure cohorts exist in the South African population:

1. Mineworkers and mill workers directly employed at asbestos extraction and processing facilities — primarily Northern Cape (Prieska, Koegas, Pomfret, Kuruman), Limpopo (Penge), Western Cape, and Mpumalanga (Msauli).
2. Environmental exposure populations — residents who lived within approximately 10 kilometres of operating mines or processing mills, including those who lived near tailings dumps or in dust-affected communities.
3. Secondary household exposure — family members (overwhelmingly women) who washed asbestos-contaminated work clothing for many years.

The Asbestos Relief Trust and Its Limits

The Asbestos Relief Trust (ART) was established in 2003 as a settlement-funded compensation mechanism arising from the Gencor and Cape PLC litigation. ART covers former workers and qualifying environmental claimants of Gencor, Msauli, and Gefco mining operations. The Kgalagadi Relief Trust (KRT) was established in 2006 to cover Kuruman-area mining operations. Since inception, ART has paid approximately R417 million to about 4,700 claimants; KRT has paid approximately R123 million to about 1,582 claimants. The average per-claim payout across both trusts is approximately R88,000, which translates to roughly US$4,700.

ART and KRT do not cover every South African asbestos exposure pathway. The trusts specifically exclude:

• Workers at non-mining sites — shipyards, refineries, power stations, naval bases, and other industrial facilities — even where asbestos exposure was equally severe.
• Workers exposed at SA mining operations that were not party to the original Cape PLC or Gencor settlement.
• Mixed-exposure claimants — environmental claimants who also had any occupational exposure, even minor or temporary employment.
• Surviving family members where the directly exposed worker died without filing.

For South African residents who fall into one or more of the excluded categories, the US trust fund system may represent a parallel compensation pathway, provided their exposure history includes the US-nexus elements described above.

How the US Trust Fund System Works

The United States asbestos trust fund system originated from a wave of corporate bankruptcies among major asbestos manufacturers and distributors beginning in the 1980s. When defendants such as Johns-Manville, Owens Corning, W.R. Grace, US Gypsum, Combustion Engineering, Federal-Mogul, and Babcock & Wilcox entered bankruptcy reorganisation, US Bankruptcy Code Section 524(g) allowed for the creation of trust funds capitalised by the bankrupt estates. These trusts assumed liability for asbestos personal injury claims against their predecessor companies and continue to pay claimants today.

There are currently approximately 60 active asbestos trust funds, with combined assets estimated at approximately US$30 billion. Each trust publishes Trust Distribution Procedures (TDPs) defining qualifying exposure categories, required documentation, and scheduled compensation values for each disease category. Mesothelioma typically commands the highest scheduled values.

A typical mesothelioma claimant with documented exposure to multiple US-manufactured products can file claims against several trusts simultaneously, with cumulative payouts in the US$300,000–US$400,000 range. None of these trusts impose a residency restriction. The eligibility criterion is product exposure, not citizenship.

Find Your Cohort — Where Did Your Exposure Happen?

Your eligibility analysis begins with your specific exposure history. The pages below organise our content by location of historical exposure, US-nexus industry, and current residence. If you are unsure which category applies to you, our intake team will walk you through it during a free, confidential review.

Cross-Border Claims Precedent in South Africa

Cross-border asbestos litigation is established practice in South Africa. The 2000 House of Lords decision in Lubbe and Others v Cape PLC permitted approximately 7,500 South African mineworker plaintiffs to bring their claims in the United Kingdom against the UK-based mining parent company — a landmark decision in transnational corporate accountability. The subsequent settlement contributed to the creation of the Asbestos Relief Trust. Separately, the 2003 Gencor settlement (approximately R460 million, also paid into ART) addressed Gencor's role in operating SA asbestos mining concessions.

On the US trust fund side, South African residents have previously received compensation from US trusts where their exposure history included US-source materials. The Cape Town-based firm Malcolm Lyons & Brivik has publicly documented its practice of representing South African seamen exposed to asbestos during port visits to US ports. The precedent for South African residents pursuing US trust fund compensation is therefore well established; what has been missing is broad awareness within the South African mesothelioma cohort that this pathway exists.

What Happens Next

The first step is a free, confidential eligibility review. Our intake team — accustomed to working with cross-border cases — will ask about your work history, the products you remember at each worksite, your diagnosis date, your treating physicians, and whether you have already filed any SA-domestic claims. There is no cost or obligation, and pursuing a US trust fund claim does not waive any rights you have under the SA Asbestos Relief Trust, Kgalagadi Relief Trust, or any other domestic pathway.

If your case shows a viable US nexus, we will explain the documentation we will need to assemble and the realistic timeline. If your case does not show a US nexus, we will be straightforward about that and, where appropriate, can refer you to South African counsel — typically Richard Spoor Inc or Abrahams Kiewitz Inc — who specialise in the SA-domestic asbestos compensation pathways.

Frequently Asked Questions